| Dr Nadia Yuhya, MD | |
|
9610 N Metro Pkwy W, Phoenix, AZ 85051-1402 | |
| (623) 583-3001 | |
| (623) 843-1560 |
| Full Name | Dr Nadia Yuhya |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 6 Years |
| Location | 9610 N Metro Pkwy W, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134613888 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 62436 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adelante Healthcare Inc | 4688588643 | 96 |
News Archive
UCLA life scientists and colleagues have produced one of the first high-resolution genetic maps for African American populations. A genetic map reveals the precise locations across the genome where DNA from a person's father and mother have been stitched together through a biological process called "recombination." This process results in new genetic combinations that are then passed on to the person's children.
Just a few days after the Supreme Court's marathon consideration of the health law, news coverage centered around political ramifications.
Saint Francis HealthCare Partners announced today that it has selected Phytel to help achieve NCQA recognition as a patient-centered medical home and will be rolling out Phytel's unique care coordination and population health management solution, Proactive Patient Outreach, in November.
In another article being released early online, Cheryl L. Rock, Ph.D., R.D., from Moores UCSD Cancer Center, La Jolla, Calif., and colleagues, conducted a randomized controlled trial of weight loss and weight maintenance in 442 overweight or obese women (BMI, 25 - 40), ages 18 to 69, over a two year period with follow-up between November 2007 and April 2010.
Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK inhibitors are in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
› Verified 1 days ago
| Entity Name | Adelante Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083772545 PECOS PAC ID: 4688588643 Enrollment ID: O20031114000335 |
News Archive
UCLA life scientists and colleagues have produced one of the first high-resolution genetic maps for African American populations. A genetic map reveals the precise locations across the genome where DNA from a person's father and mother have been stitched together through a biological process called "recombination." This process results in new genetic combinations that are then passed on to the person's children.
Just a few days after the Supreme Court's marathon consideration of the health law, news coverage centered around political ramifications.
Saint Francis HealthCare Partners announced today that it has selected Phytel to help achieve NCQA recognition as a patient-centered medical home and will be rolling out Phytel's unique care coordination and population health management solution, Proactive Patient Outreach, in November.
In another article being released early online, Cheryl L. Rock, Ph.D., R.D., from Moores UCSD Cancer Center, La Jolla, Calif., and colleagues, conducted a randomized controlled trial of weight loss and weight maintenance in 442 overweight or obese women (BMI, 25 - 40), ages 18 to 69, over a two year period with follow-up between November 2007 and April 2010.
Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK inhibitors are in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nadia Yuhya, MD 3033 N Central Ave Ste 145, Phoenix, AZ 85012-2808 Ph: (623) 583-3001 | Dr Nadia Yuhya, MD 9610 N Metro Pkwy W, Phoenix, AZ 85051-1402 Ph: (623) 583-3001 |
News Archive
UCLA life scientists and colleagues have produced one of the first high-resolution genetic maps for African American populations. A genetic map reveals the precise locations across the genome where DNA from a person's father and mother have been stitched together through a biological process called "recombination." This process results in new genetic combinations that are then passed on to the person's children.
Just a few days after the Supreme Court's marathon consideration of the health law, news coverage centered around political ramifications.
Saint Francis HealthCare Partners announced today that it has selected Phytel to help achieve NCQA recognition as a patient-centered medical home and will be rolling out Phytel's unique care coordination and population health management solution, Proactive Patient Outreach, in November.
In another article being released early online, Cheryl L. Rock, Ph.D., R.D., from Moores UCSD Cancer Center, La Jolla, Calif., and colleagues, conducted a randomized controlled trial of weight loss and weight maintenance in 442 overweight or obese women (BMI, 25 - 40), ages 18 to 69, over a two year period with follow-up between November 2007 and April 2010.
Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK inhibitors are in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
› Verified 1 days ago
Dr. Serena Dawn Woods-grimm, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 201 N Central Ave, Phoenix, AZ 85004 Phone: 602-221-6326 | |
Michael Devin Taylor, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2927 N 7th Ave, Peppertree - Family Medicine #3, Phoenix, AZ 85013 Phone: 602-406-3153 Fax: 602-406-4122 | |
Dr. Umar Iqbal, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2927 N 7th Ave, Peppertree Building - Window #3, Phoenix, AZ 85013 Phone: 602-406-3153 Fax: 602-406-7176 | |
Jessica Ann Wright, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-933-1000 | |
Meggan E Bauer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4250 E Camelback Rd Ste K100, Phoenix, AZ 85018 Phone: 602-224-9218 | |
Dr. James W. Fisher, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12450 N 32nd St Ste 3, Phoenix, AZ 85032 Phone: 602-996-0924 Fax: 602-482-2624 | |
Geoffrey Peter Radoff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 West Greenway, Suite 210, Phoenix, AZ 85023 Phone: 602-993-0200 Fax: 602-993-0207 |